December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

90.59 +0.17 (+0.19%)
Streaming Delayed Price Updated: 3:01 PM EDT, Apr 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
These S&P500 stocks that are showing activity before the opening bell on Monday. ↗
Via Chartmill
News headline image
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6? ↗
Organon & Co. develops branded and biosimilar therapies with a focus on women’s health and specialty pharmaceuticals. 
Via The Motley Fool
News headline image
Surgical Equipment & Consumables - Diversified Stocks Q4 In Review: Zimmer Biomet (NYSE:ZBH) Vs Peers
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence Economy World Trade
News headline image
Stryker Corporation (SYK): Navigating Innovation and Resilience in the Wake of a Digital Crisis
As of March 16, 2026, the medical technology landscape is grappling with a stark reminder of the vulnerabilities inherent in the digital shift of healthcare. Stryker Corporation (NYSE: SYK), a global... 
Via Finterra
Topics Earnings Economy Hacking
Zimmer Biomet Holdings Inc (NYSE:ZBH) Presents a Compelling Case for Value Investors ↗
Via Chartmill
News headline image
3 Healthcare Stocks We Think Twice About
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead
Over the past six months, Zimmer Biomet’s stock price fell to $99.27. Shareholders have lost 6.1% of their capital, which is disappointing considering the S&P 500 has climbed by 7.6%. This might have... 
Via StockStory
Topics Stocks
News headline image
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead
Over the last six months, Zimmer Biomet’s shares have sunk to $98.28, producing a disappointing 5.8% loss - a stark contrast to the S&P 500’s 6.7% gain. This may have investors wondering how to... 
Via StockStory
Topics Stocks
News headline image
The Top 5 Analyst Questions From Zimmer Biomet’s Q4 Earnings Call
Zimmer Biomet’s fourth quarter results were greeted positively by the market, with management crediting strong execution in the U.S. and robust demand for recently launched products as key drivers. CEO... 
Via StockStory
Topics Earnings
Zimmer Biomet Holdings Inc (NYSE:ZBH): A Durable Dividend Cornerstone for Income Investors ↗
Via Chartmill
News headline image
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH ↗
Via MarketBeat
News headline image
ZBH Q4 Deep Dive: U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum
Medical device company Zimmer Biomet (NYSE:ZBH) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 10.9% year on year to $2.24 billion. Its non-GAAP profit of $2.42 per... 
Via StockStory
News headline image
Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript ↗
Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations
Medical device company Zimmer Biomet (NYSE:ZBH) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 10.9% year on year to $2.24 billion. Its non-GAAP profit of $2.42 per... 
Via StockStory
Topics World Trade
Zimmer Biomet Holdings Inc (NYSE:ZBH) Screened as a 'Decent Value' Investment Opportunity ↗
Via Chartmill
Zimmer Biomet Holdings Inc. (NYSE:ZBH) Offers a Reliable Dividend Backed by Steady Fundamentals ↗
Via Chartmill
News headline image
What To Expect From Zimmer Biomet’s (ZBH) Q4 Earnings
Medical device company Zimmer Biomet (NYSE:ZBH) will be announcing earnings results this Tuesday before market open. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
3 Reasons ZBH is Risky and 1 Stock to Buy Instead
Over the past six months, Zimmer Biomet’s shares (currently trading at $86.64) have posted a disappointing 6.2% loss, well below the S&P 500’s 9.6% gain. This might have investors contemplating their... 
Via StockStory
Topics Stocks
News headline image
3 Value Stocks with Open Questions
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
News headline image
Q3 Rundown: Zimmer Biomet (NYSE:ZBH) Vs Other Surgical Equipment & Consumables - Diversified Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Zimmer Biomet (NYSE:ZBH) and... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Cash-Producing Stocks with Open Questions
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Profitable Stock to Research Further and 2 Facing Challenges
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
News headline image
Solventum (SOLV): The 3M Spin-Off That Found Its Rhythm – A 2026 Deep-Dive Analysis
Date: January 14, 2026 Introduction Since its high-profile separation from industrial conglomerate 3M Company (NYSE: MMM) in April 2024, Solventum Corporation (NYSE: SOLV) has undergone a profound... 
Via Finterra
Topics Artificial Intelligence World Trade
News headline image
3 S&P 500 Stocks We Approach with Caution
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,... 
Via StockStory
Topics Stocks
News headline image
Top gainers and losers in the S&P500 index during Monday's after-hours session. ↗
Wondering what's happening in today's after-hours session with S&P500 stocks? Stay tuned for the latest updates on movers and shakers. 
Via Chartmill
News headline image
Zimmer Biomet Holdings Inc (NYSE:ZBH) Presents a Compelling Value Case for Disciplined Investors ↗
Zimmer Biomet (ZBH) presents a value investing case, trading at a significant discount to the market and its industry while maintaining solid profitability and financial health. 
Via Chartmill
News headline image
Zimmer Biomet Holdings Inc (NYSE:ZBH) Presents a Notable Case for Value Investors ↗
Zimmer Biomet (ZBH) presents a compelling value investment case with strong valuation metrics, solid earnings capability, and a stable balance sheet in the healthcare sector. 
Via Chartmill
News headline image
Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles
As of December 12, 2025, the financial markets are witnessing a significant "Great Rotation," a pronounced shift of capital from high-growth technology and Artificial Intelligence (AI) stocks to more... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Zimmer Biomet, Cigna, Universal Health Services, Henry Schein, and Sotera Health Company Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy Government
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Gauzy and Zimmer Biomet and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.